Secretive Oraya raises $18M for eye devices
See our story on this Menlo Park, Calif., ophthalmology-device company at VentureBeat Life Sciences.
Next Story: Alder Bio and its yeast-produced antibodies take in $40M
Previous Story: Secretive Oraya raises more funds for eye devices
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.